156 related articles for article (PubMed ID: 34259565)
1. Low Carbohydrate Diets and Estimated Cardiovascular and Metabolic Syndrome Risk in Prostate Cancer.
Freedland SJ; Howard LE; Ngo A; Ramirez-Torres A; Csizmadi I; Cheng S; Mack A; Lin PH
J Urol; 2021 Dec; 206(6):1411-1419. PubMed ID: 34259565
[TBL] [Abstract][Full Text] [Related]
2. A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial.
Freedland SJ; Howard L; Allen J; Smith J; Stout J; Aronson W; Inman BA; Armstrong AJ; George D; Westman E; Lin PH
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):428-437. PubMed ID: 30664736
[TBL] [Abstract][Full Text] [Related]
3. A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2).
Freedland SJ; Allen J; Jarman A; Oyekunle T; Armstrong AJ; Moul JW; Sandler HM; Posadas E; Levin D; Wiggins E; Howard LE; Wu Y; Lin PH
Clin Cancer Res; 2020 Jun; 26(12):3035-3043. PubMed ID: 32108029
[TBL] [Abstract][Full Text] [Related]
4. Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial.
Chi JT; Lin PH; Tolstikov V; Howard L; Chen EY; Bussberg V; Greenwood B; Narain NR; Kiebish MA; Freedland SJ
Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):770-777. PubMed ID: 35338353
[TBL] [Abstract][Full Text] [Related]
5. Low-carbohydrate diet and cardiovascular diseases in Iranian population: Tehran Lipid and Glucose Study.
Farhadnejad H; Asghari G; Teymoori F; Tahmasebinejad Z; Mirmiran P; Azizi F
Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):581-588. PubMed ID: 32008914
[TBL] [Abstract][Full Text] [Related]
6. Low carbohydrate diet: are concerns with saturated fat, lipids, and cardiovascular disease risk justified?
Diamond DM; O'Neill BJ; Volek JS
Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):291-300. PubMed ID: 32773573
[TBL] [Abstract][Full Text] [Related]
7. Weight loss via a low-carbohydrate diet improved the intestinal permeability marker, zonulin, in prostate cancer patients.
Lin PH; Howard L; Freedland SJ
Ann Med; 2022 Dec; 54(1):1221-1225. PubMed ID: 35486445
[TBL] [Abstract][Full Text] [Related]
8. Effects of a 6-month, low-carbohydrate diet on glycaemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes: An open-label randomized controlled trial.
Gram-Kampmann EM; Hansen CD; Hugger MB; Jensen JM; Brønd JC; Hermann AP; Krag A; Olsen MH; Beck-Nielsen H; Højlund K
Diabetes Obes Metab; 2022 Apr; 24(4):693-703. PubMed ID: 34984805
[TBL] [Abstract][Full Text] [Related]
9. Benefits of resistance training on body composition and glucose clearance are inhibited by long-term low carbohydrate diet in rats.
Stotzer US; Pisani GFD; Canevazzi GHR; Shiguemoto GE; Duarte ACGO; Perez SEA; Selistre-de-Araújo HS
PLoS One; 2018; 13(12):e0207951. PubMed ID: 30532163
[TBL] [Abstract][Full Text] [Related]
10. Low-carbohydrate diet score is associated with improved blood pressure and cardio-metabolic risk factors among obese adults.
Pour Abbasi MS; Shojaei N; Farhangi MA
Physiol Rep; 2022 Jul; 10(13):e15375. PubMed ID: 35822420
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Different Degrees of Carbohydrate Restriction and Carbohydrate Replacement on Cardiometabolic Risk Markers in Humans-A Systematic Review and Meta-Analysis.
Fechner E; Smeets ETHC; Schrauwen P; Mensink RP
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32252374
[TBL] [Abstract][Full Text] [Related]
12. Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial.
Shemirani F; Djafarian K; Fotouhi A; Azadbakht L; Rezaei N; Chamari M; Shabani S; Mahmoudi M
Clin Nutr ESPEN; 2022 Apr; 48():87-98. PubMed ID: 35331539
[TBL] [Abstract][Full Text] [Related]
13. Lower carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling of prospective studies.
Mazidi M; Katsiki N; Mikhailidis DP; Sattar N; Banach M
Eur Heart J; 2019 Sep; 40(34):2870-2879. PubMed ID: 31004146
[TBL] [Abstract][Full Text] [Related]
14. Effect of low-carbohydrate diets on cardiometabolic risk, insulin resistance, and metabolic syndrome.
O'Neill BJ
Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):301-307. PubMed ID: 32773574
[TBL] [Abstract][Full Text] [Related]
15. The Low-Carbohydrate Diet: Short-Term Metabolic Efficacy Versus Longer-Term Limitations.
Barber TM; Hanson P; Kabisch S; Pfeiffer AFH; Weickert MO
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916669
[TBL] [Abstract][Full Text] [Related]
16. The association between low-carbohydrate diet score and metabolic syndrome among Iranian adults.
Sangsefidi ZS; Lorzadeh E; Nadjarzadeh A; Mirzaei M; Hosseinzadeh M
Public Health Nutr; 2021 Dec; 24(18):6299-6308. PubMed ID: 34294177
[TBL] [Abstract][Full Text] [Related]
17. Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet.
Diamond DM; Bikman BT; Mason P
Curr Opin Endocrinol Diabetes Obes; 2022 Oct; 29(5):497-511. PubMed ID: 35938780
[TBL] [Abstract][Full Text] [Related]
18. Association between remnant cholesterol, metabolic syndrome, and cardiovascular disease: post hoc analysis of a prospective national cohort study.
Jin J; Hu X; Francois M; Zeng P; Wang W; Yu B; Zhou Y; Dong H
Eur J Med Res; 2023 Oct; 28(1):420. PubMed ID: 37821969
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
